Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2014; 20(22): 6860-6868
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6860
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6860
Table 1 Clinico-epidemiological details of subjects enrolled in study n (%)
Clinico-epidemiological characteristics | Normal | Pre-cancer | Cancer (adenocarcinoma) |
Total subjects | 61 | 30 | 65 |
Gender | |||
Male | 42 (68.9) | 17 (56.7) | 42 (64.6) |
Female | 19 (31.1) | 13 (43.3) | 23 (35.4) |
Histopathological classification of lesions | |||
Intestinal metaplasia | - | 15 (50) | - |
Dysplasia | - | 15 (50) | - |
Diffuse adenocarcinoma | - | - | 44 (67.7) |
Intestinal adenocarcinoma | - | - | 21 (32.3) |
Age (yr) (median) | 7-85 (40) | 13-78 (41.5) | 22-90 (55) |
Habits1 | |||
Tobacco chewers | 28 (45.9) | 15 (50) | 24 (37) |
Tobacco non-chewers | 33 (54.1) | 15 (50) | 41 (63) |
Tobacco smokers | 22 (36.1) | 11 (36.7) | 20 (30.8) |
Tobacco non-smokers | 39 (64) | 19 (63.3) | 45 (69.2) |
Alcoholic | 15 (24.6) | 8 (26.7) | 16 (24.6) |
Non-alcoholic | 46 (75.4) | 22 (73.3) | 49 (75.4) |
Multiple habits | 22 (36.1) | 9 (30) | 16 (24.6) |
Table 2 Primer sequences, primer annealing positions, expected lengths of amplified DNA products, and amplification cycle of polymerase chain reaction performed in the study
Primer | Sequence | Annealing position | Product length (bp) | Amplification cycle |
Hp ureC-F | 5’-AAG CTT TTA GGG GTG TTA GGG GTT T-3’ | 1293-1318 | 294 | 94 °C, 10’, 36 cycle (94 °C, 2’; 55 °C, 2’; 72 °C, 2’), 72 °C, 10’ |
Hp ureC-R | 5’-AAG CTT ACT TTC TAA CAC TAA CGC-3’ | 1587-1563 | ||
Hp cagA-F | 5’-AAT ACA CCA ACG CCT CCA AG-3’ | 2593-2612 | 400 | 94 °C, 4’, 39 cycle (94 °C, 2’; 59 °C, 2’; 72 °C, 2’), 72 °C, 10’ |
Hp cagA-R | 5’-TTG TTG CCG CTT TTG CTC TC-3’ | 2992-2973 | ||
β-globin-F | 5’-GAA GAG CCA AGG ACA GGT AC-3’ | 195-176 | 268 | 94 °C, 4’, 30 cycle (95 °C, 30’’; 55 °C, 30’’; 72 °C, 1’), 72 °C, 10’ |
β-globin-R | 5’-CAA CTT CAT CCA CGT TCA ACC-3’ | 54-73 |
Table 3 Analysis of Helicobacter pylori gene expression in normal gastric tissues with clinico-epidemiological parameters n (%)
Clinico-epidemiological characteristics | Total cases, n | ureC positive | P | cagA positive | P | Hp +ve | P |
Normal | 61 | 33 (54.1) | - | 21 (34.4) | - | 37 (60.7) | - |
Age (median 40 yr; range: 7-85 yr) | |||||||
< 40 | 29 | 13 (44.8) | 0.167 | 8 (27.6) | 0.284 | 15 (51.7) | 0.174 |
≥ 40 | 32 | 20 (62.5) | 13 (40.6) | 22 (68.8) | |||
Gender | |||||||
Male | 42 | 18 (42.9) | 0.009 | 14 (33.3) | 0.789 | 22 (52.4) | 0.049 |
Female | 19 | 15 (78.9) | 7 (36.8) | 15 (78.9) | |||
Habits1 | |||||||
Tobacco chewers | 28 | 19 (67.9) | 0.047 | 14 (50) | 0.018 | 20 (71.4) | 0.113 |
Tobacco non-chewers | 33 | 14 (42.4) | 7 (21.2) | 17 (51.5) | |||
Tobacco smokers | 22 | 13 (59.1) | 0.557 | 11 (50) | 0.055 | 15 (68.2) | 0.366 |
Tobacco non-smokers | 39 | 20 (51.3) | 10 (25.6) | 22 (56.4) | |||
Alcoholic | 15 | 9 (60) | 0.597 | 6 (40) | 0.601 | 10 (66.7) | 0.583 |
Non-alcoholic | 46 | 24 (52.2) | 15 (32.6) | 27 (58.7) | |||
Multiple habits | 22 | 14 (63.6) | 0.262 | 10 (45.5) | 0.173 | 15 (68.2) | 0.366 |
Table 4 Analysis of Helicobacter pylori gene expression in pre-cancer gastric tissues with clinico-epidemiological parameters n (%)
Clinico-epidemiological characteristics | Total cases, n | ureC positive | P | cagA positive | P | Hp +ve | P |
Pre-cancer | 30 | 27 (90) | 0.0011 | 22 (73.3) | < 0.0011 | 28 (93.3) | < 0.0011 |
Age (median: 41.5 yr; range: 13-78 yr) | |||||||
< 41.5 | 15 | 14 (93.3) | 0.543 | 11 (73.3) | 1.00 | 14 (93.3) | 1.00 |
≥ 41.5 | 15 | 13 (86.7) | 11 (73.3) | 14 (93.3) | |||
Gender | |||||||
Male | 17 | 15 (88.2) | 0.713 | 14 (82.4) | 0.201 | 16 (94.1) | 0.844 |
Female | 13 | 12 (92.3) | 8 (61.5) | 12 (92.3) | |||
Types | |||||||
Dysplasia | 12 | 12 (100) | 0.136 | 9 (75) | 0.866 | 12 (100) | 0.503 |
Intestinal metaplasia | 18 | 15 (83.3) | 13 (72.2) | 16 (88.9) | |||
Habits2 | |||||||
Tobacco chewers | 15 | 13 (86.7) | 0.543 | 12 (80) | 0.409 | 14 (93.3) | 1.000 |
Tobacco non-chewers | 15 | 14 (93.3) | 10 (66.7) | 14 (93.3) | |||
Tobacco smokers | 11 | 11 (100) | 0.165 | 10 (90.9) | 0.098 | 11 (100) | 0.265 |
Tobacco non-smokers | 19 | 16 (84.2) | 12 (63.2) | 17 (89.5) | |||
Alcoholic | 8 | 8 (100) | 0.271 | 7 (87.5) | 0.290 | 8 (100) | 0.377 |
Non-alcoholic | 22 | 19 (86.4) | 15 (68.2) | 20 (90.9) | |||
Multiple habits | 9 | 9 (100) | 0.232 | 8 (88.9) | 0.207 | 9 (100) | 0.338 |
Table 5 Analysis of Helicobacter pylori gene expression in adenocarcinoma gastric tissues with clinico-epidemiological parameters n (%)
Clinico-epidemiological Characteristics | Total cases, n | ureC positive | P | cagA positive | P | Hp +ve | P |
Adenocarcinoma | 65 | 33 (50.8) | < 0.0011 | 17 (26.2) | < 0.0011 | 34 (52.3) | < 0.0011 |
0.7082 | 0.3122 | 0.3452 | |||||
Age (median 55 yr; range: 22-90 yr) | |||||||
< 55 | 31 | 14 (45.2) | 0.388 | 10 (32.3) | 0.285 | 15 (48.4) | 0.546 |
≥ 55 | 34 | 19 (55.9) | 7 (20.6) | 19 (55.9) | |||
Gender | |||||||
Male | 42 | 22 (52.4) | 0.725 | 10 (23.8) | 0.561 | 23 (54.8) | 0.592 |
Female | 23 | 11 (47.8) | 7 (30.4) | 11 (47.8) | |||
Types | |||||||
Diffuse | 44 | 24 (54.5) | 0.378 | 13 (29.5) | 0.368 | 25 (56.8) | 0.292 |
Intestinal | 21 | 9 (42.9) | 4 (19) | 9 (42.9) | |||
Habits3 | |||||||
Tobacco chewers | 24 | 19 (79.2) | < 0.001 | 12 (50) | 0.001 | 19 (79.2) | 0.001 |
Tobacco non-chewers | 41 | 14 (34.1) | 5 (12.2) | 15 (36.6) | |||
Tobacco smokers | 20 | 10 (50) | 0.934 | 8 (40) | 0.090 | 11 (55) | 0.772 |
Tobacco non-smokers | 45 | 23 (51.1) | 9 (20) | 23 (51.1) | |||
Alcoholic | 16 | 9 (56.2) | 0.614 | 4 (25) | 0.904 | 9 (56.3) | 0.716 |
Non-alcoholic | 49 | 24 (49) | 13 (26.5) | 25 (51) | |||
Multiple habits | 16 | 9 (56.2) | 0.614 | 6 (37.5) | 0.234 | 9 (56.3) | 0.716 |
-
Citation: Pandey A, Tripathi SC, Mahata S, Vishnoi K, Shukla S, Misra SP, Misra V, Hedau S, Mehrotra R, Dwivedi M, Bharti AC. Carcinogenic
Helicobacter pylori in gastric pre-cancer and cancer lesions: Association with tobacco-chewing. World J Gastroenterol 2014; 20(22): 6860-6868 - URL: https://www.wjgnet.com/1007-9327/full/v20/i22/6860.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i22.6860